Fusariosis

Fabio Nucci; Simone A. Nouér; Domenico Capone; Elias Anaissie; Marcio Nucci

doi:10.1055/s-0035-1562897

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2015; 36(05): 706-714
DOI: 10.1055/s-0035-1562897

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Fusariosis

Fabio Nucci

¹Hematology Service, University Hospital, Universidade Federal Fluminense, Niteroi, Brazil

,

Simone A. Nouér

²Department of Preventive Medicine, University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

,

Domenico Capone

²Department of Preventive Medicine, University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

³Radiology Service, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

,

Elias Anaissie

⁴Division of Hematology/Oncology, University of Cincinnati, Cincinnati, Ohio

,

Marcio Nucci

⁵Department of Internal Medicine, University Hospital, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

› Institutsangaben

Abstract

Fusarium species are frequent agents of onychomycosis and fungal keratitis, and occasional agents of invasive disease. The clinical spectrum of fusariosis in the lungs includes allergic disease (allergic bronchopulmonary fusariosis), hypersensitivity pneumonitis, colonization of a preexisting cavity, and pneumonia. Fusarial pneumonia occurs almost exclusively in severely immunocompromised patients, especially acute leukemia patients and recipients of allogeneic cell transplantation. In such patients, invasive fusariosis is usually disseminated, and pneumonia occurs in almost 50% of cases. The radiologic picture is similar to invasive aspergillosis, with alveolar infiltrates, nodules with or without halo sign, ground-glass infiltrates, and pleural effusions. Different from aspergillosis is the frequent occurrence of disseminated nodular and papular skin lesions and positive blood cultures. The drug of choice for the treatment of invasive fusariosis is either voriconazole or liposomal amphotericin B. The outcome is usually poor, and largely dependent on the recovery of the immune status of the host, particularly neutropenia.

Keywords

Fusarium - fusariosis - immunocompromised - pneumonia

Volltext

Referenzen

References
1 Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994; 7 (4) 479-504
2 Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20 (4) 695-704
3 Nucci M, Anaissie E. Emerging fungi. Infect Dis Clin North Am 2006; 20 (3) 563-579
4 Vacher G, Niculita-Hirzel H, Roger T. Immune responses to airborne fungi and non-invasive airway diseases. Semin Immunopathol 2015; 37 (2) 83-96
5 Bezerra GF, de Almeida FC, Neto da Silva MA , et al. Respiratory allergy to airborne fungi in São Luís—MA: clinical aspects and levels of IgE in a structured asthma program. J Asthma 2014; 51 (10) 1028-1034
6 Chowdhary A, Agarwal K, Kathuria S, Gaur SN, Randhawa HS, Meis JF. Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview. Crit Rev Microbiol 2014; 40 (1) 30-48
7 Muñoz-Del-Castillo F, Jurado-Ramos A, Soler R , et al. Fungal sensitization in nasal polyposis. J Investig Allergol Clin Immunol 2009; 19 (1) 6-12
8 Nucci M, Anaissie EJ, Queiroz-Telles F , et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003; 98 (2) 315-319
9 Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997; 90 (3) 999-1008
10 Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35 (8) 909-920
11 O'Donnell K, Sutton DA, Fothergill A , et al. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol 2008; 46 (8) 2477-2490
12 Dóczi I, Gyetvai T, Kredics L, Nagy E. Involvement of Fusarium spp. in fungal keratitis. Clin Microbiol Infect 2004; 10 (9) 773-776
13 Godoy P, Nunes E, Silva V, Tomimori-Yamashita J, Zaror L, Fischman O. Onychomycosis caused by Fusarium solani and Fusarium oxysporum in São Paulo, Brazil. Mycopathologia 2004; 157 (3) 287-290
14 Warkentien T, Rodriguez C, Lloyd B , et al; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group. Invasive mold infections following combat-related injuries. Clin Infect Dis 2012; 55 (11) 1441-1449
15 Gaur S, Rajgopal A, Ashbee R. A successfully treated case of peritonitis due to Fusarium dimerum . J Infect 2010; 61 (1) 86-88
16 García-Tapia A, Aznar E, García-Martos P , et al. Fusarium peritonitis in a patient on peritoneal dialysis. Rev Iberoam Micol 1999; 16 (3) 166-167
17 Murray CK, Beckius ML, McAllister K. Fusarium proliferatum superficial suppurative thrombophlebitis. Mil Med 2003; 168 (5) 426-427
18 Jakle C, Leek JC, Olson DA, Robbins DL. Septic arthritis due to Fusarium solani . J Rheumatol 1983; 10 (1) 151-153
19 Terada M, Fujita J, Watanabe S , et al. Olecranon bursa with Fusarium solani infection in an otherwise healthy patient. Mycoses 2011; 54 (6) e853-e855
20 Sierra-Hoffman M, Paltiyevich-Gibson S, Carpenter JL, Hurley DL. Fusarium osteomyelitis: case report and review of the literature. Scand J Infect Dis 2005; 37 (3) 237-240
21 Moschovi M, Trimis G, Anastasopoulos J, Kanariou M, Raftopoulou A, Tzortzatou-Stathopoulou F. Subacute vertebral osteomyelitis in a child with diabetes mellitus associated with Fusarium . Pediatr Int 2004; 46 (6) 740-742
22 Bader M, Jafri AK, Krueger T, Kumar V. Fusarium osteomyelitis of the foot in a patient with diabetes mellitus. Scand J Infect Dis 2003; 35 (11-12) 895-896
23 Nuovo MA, Simmonds JE, Chacho MS, McKitrick JC. Fusarium solani osteomyelitis with probable nosocomial spread. Am J Clin Pathol 1988; 90 (6) 738-741
24 Proença-Pina J, Ssi Yan Kai I, Bourcier T, Fabre M, Offret H, Labetoulle M. Fusarium keratitis and endophthalmitis associated with lens contact wear. Int Ophthalmol 2010; 30 (1) 103-107
25 Dananche C, Cassier P, Sautour M , et al. Fungaemia caused by Fusarium proliferatum in a patient without definite immunodeficiency. Mycopathologia 2015; 179 (1-2) 135-140
26 Georgiadou SP, Velegraki A, Arabatzis M , et al. Cluster of Fusarium verticillioides bloodstream infections among immunocompetent patients in an internal medicine department after reconstruction works in Larissa, Central Greece. J Hosp Infect 2014; 86 (4) 267-271
27 Kang Y, Li L, Zhu J, Zhao Y, Zhang Q. Identification of Fusarium from a patient with fungemia after multiple organ injury. Mycopathologia 2013; 176 (1-2) 151-155
28 Kurien M, Anandi V, Raman R, Brahmadathan KN. Maxillary sinus fusariosis in immunocompetent hosts. J Laryngol Otol 1992; 106 (8) 733-736
29 Lee SK, Kim SS, Nahm DH , et al. Hypersensitivity pneumonitis caused by Fusarium napiforme in a home environment. Allergy 2000; 55 (12) 1190-1193
30 Macêdo DP, Neves RP, Fontan J, Souza-Motta CM, Lima D. A case of invasive rhinosinusitis by Fusarium verticillioides (Saccardo) Nirenberg in an apparently immunocompetent patient. Med Mycol 2008; 46 (5) 499-503
31 Rajmane VS, Rajmane ST, Patil VC, Patil AB, Mohite ST. Maxillary rhinosinusitis due to Fusarium species leading to cavernous sinus thrombosis. J Mycol Med 2013; 23 (1) 53-56
32 Sander A, Beyer U, Amberg R. Systemic Fusarium oxysporum infection in an immunocompetent patient with an adult respiratory distress syndrome (ARDS) and extracorporal membrane oxygenation (ECMO). Mycoses 1998; 41 (3-4) 109-111
33 Shono K. Disseminated Fusarium solani infection in patients undergoing hematopoietic stem cell transplantation [in Japanese]. Nippon Ishinkin Gakkai Zasshi 2003; 44 (3) 187-191
34 Madariaga MG, Kohl S. Disseminated fusariosis presenting with pulmonary nodules following a line infection. Braz J Infect Dis 2006; 10 (6) 419
35 Kontoyiannis DP, Marr KA, Park BJ , et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50 (8) 1091-1100
36 Pagano L, Caira M, Nosari A , et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study—Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Clin Infect Dis 2007; 45 (9) 1161-1170
37 Pagano L, Caira M, Candoni A , et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91 (8) 1068-1075
38 Nucci M, Garnica M, Gloria AB , et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 2013; 19 (8) 745-751
39 Mohanty NK, Sahu S. Fusarium solani infection in a kidney transplant recipient. Indian J Nephrol 2014; 24 (5) 312-314
40 Girardi M, Glusac EJ, Imaeda S. Subcutaneous Fusarium foot abscess in a renal transplant patient. Cutis 1999; 63 (5) 267-270
41 Garbino J, Uckay I, Rohner P, Lew D, Van Delden C. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Int 2005; 18 (5) 613-618
42 Cocuroccia B, Gaido J, Gubinelli E, Annessi G, Girolomoni G. Localized cutaneous hyalohyphomycosis caused by a Fusarium species infection in a renal transplant patient. J Clin Microbiol 2003; 41 (2) 905-907
43 Halpern M, Balbi E, Carius L , et al. Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report. Transplant Proc 2010; 42 (2) 599-600
44 Cocchi S, Codeluppi M, Venturelli C , et al. Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole. Diagn Microbiol Infect Dis 2011; 71 (4) 438-441
45 Herbrecht R, Kessler R, Kravanja C, Meyer MH, Waller J, Letscher-Bru V. Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. J Heart Lung Transplant 2004; 23 (12) 1451-1454
46 Arney KL, Tiernan R, Judson MA. Primary pulmonary involvement of Fusarium solani in a lung transplant recipient. Chest 1997; 112 (4) 1128-1130
47 Terasaki JM, Shah SK, Schnadig VJ, Valentine VG. Airway complication contributing to disseminated fusariosis after lung transplantation. Transpl Infect Dis 2014; 16 (4) 621-624
48 Carneiro HA, Coleman JJ, Restrepo A, Mylonakis E. Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore) 2011; 90 (1) 69-80
49 Eljaschewitsch J, Sandfort J, Tintelnot K, Horbach I, Ruf B. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B. Mycoses 1996; 39 (3-4) 115-119
50 Esnakula AK, Summers I, Naab TJ. Fatal disseminated Fusarium infection in a human immunodeficiency virus positive patient. Case Rep Infect Dis 2013; 2013: 379320
51 Mardiak J, Danisovicová A, Trupl J, Sloboda J, Jesenská Z, Krcméry Jr V. Three cases of fatal infection due to Fusarium solani in patients with cancer. Clin Infect Dis 1993; 17 (5) 930-932
52 Glasgow BJ, Engstrom Jr RE, Holland GN, Kreiger AE, Wool MG. Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol 1996; 114 (7) 873-877
53 Benjamin RP, Callaway L, Conant NF. Facial granuloma associated with Fusarium infection. Arch Dermatol 1970; 101 (5) 598-600
54 Mansoory D, Roozbahany NA, Mazinany H, Samimagam A. Chronic Fusarium infection in an adult patient with undiagnosed chronic granulomatous disease. Clin Infect Dis 2003; 37 (7) e107-e108
55 Steinberg GK, Britt RH, Enzmann DR, Finlay JL, Arvin AM. Fusarium brain abscess. Case report. J Neurosurg 1983; 58 (4) 598-601
56 Guimerá-Martín-Neda F, García-Bustínduy M, Noda-Cabrera A, Sánchez-González R, Montelongo RG. Cutaneous infection by Fusarium: successful treatment with oral voriconazole. Br J Dermatol 2004; 150 (4) 777-778
57 Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34 (7) 909-917
58 Garnica M, da Cunha MO, Portugal R, Maiolino A, Colombo AL, Nucci M. Risk factors for invasive Fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients. Clin Infect Dis 2015; 60 (6) 875-880
59 Backman KS, Roberts M, Patterson R. Allergic bronchopulmonary mycosis caused by Fusarium vasinfectum . Am J Respir Crit Care Med 1995; 152 (4, Pt 1) 1379-1381
60 Rojas-Tula DG, Gómez-Fernández M, García-López JJ , et al. Endobronchial cryotherapy for a mycetoma. J Bronchology Interv Pulmonol 2013; 20 (4) 330-332
61 Gorman SR, Magiorakos AP, Zimmerman SK, Craven DE. Fusarium oxysporum pneumonia in an immunocompetent host. South Med J 2006; 99 (6) 613-616
62 Katkar VJ, Tankhiwale SS, Kurhade A. Fusarium soloni mycetoma. Indian J Dermatol 2011; 56 (3) 315-317
63 Sidhu S, Chander J, Singh K. Perinephric abscess caused by Fusarium chlamydosporum in an immunocompetent child: case report and identification of the morphologically atypical fungal strain. Indian J Pathol Microbiol 2013; 56 (3) 312-314
64 Singhal KV, Saoji V, Saoji SV. Fusarium skin infection: a case report. Dermatol Online J 2012; 18 (4) 6
65 Su CC, Hsu HJ, Wu JJ, Chou CW. Diagnosis of fusariosis in urine cytology. J Clin Pathol 2007; 60 (4) 422-424
66 Yamada Y, Nishioka G, Makimura K, Oka M. Localized cutaneous fusariosis after long-term topical application of corticosteroids in a healthy elderly woman. Eur J Dermatol 2012; 22 (4) 555-559
67 Yan X, Yu C, Shi Z, Wang S, Zhang F. Nasal cutaneous infection in a healthy boy caused by Fusarium moniliforme . Pediatr Dermatol 2013; 30 (4) e43-e45
68 Avelino-Silva VI, Ramos JF, Leal FE, Testagrossa L, Novis YS. Disseminated Fusarium infection in autologous stem cell transplant recipient. Braz J Infect Dis 2015; 19 (1) 90-93
69 Bose P, Parekh HD, Holter JL, Greenfield RA. Disseminated fusariosis occurring in two patients despite posaconazole prophylaxis. J Clin Microbiol 2011; 49 (4) 1674-1675
70 Busemann C, Krüger W, Schwesinger G , et al. Myocardial and aortal involvement in a case of disseminated infection with Fusarium solani after allogeneic stem cell transplantation: report of a case. Mycoses 2009; 52 (4) 372-376
71 Calcaterra D, Karam K, Suzuki Y. Computed tomography findings in a patient with fungal aortitis: acute aortic syndrome secondary to fusariosis. Interact Cardiovasc Thorac Surg 2013; 17 (1) 171-172
72 Cesaro S, Marinello S, Alessia B , et al. Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach. Mycoses 2010; 53 (2) 181-185
73 Chan TS, Gill H, Hwang YY , et al. Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients. Ann Hematol 2014; 93 (3) 493-498
74 Collado C, Medina L, Zorraquino A , et al. Cutaneous fusariosis by a species of the Fusarium dimerum species complex in a patient with acute myeloblastic leukemia. Rev Iberoam Micol 2013; 30 (2) 119-121
75 Cudillo L, Girmenia C, Santilli S , et al. Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis. Clin Infect Dis 2005; 40 (8) 1212-1213
76 Cudillo L, Tendas A, Picardi A , et al. Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia. Ann Hematol 2006; 85 (2) 136-138
77 Cuellar-Rodriguez J, Bravo LT, Oethinger M, Fraser T, Mossad SB. Disseminated fusariosis in a recipient of a bone-marrow transplant. Lancet Infect Dis 2009; 9 (8) 520
78 Dai W, Dharamsi JW, Soliman S , et al. Cutaneous fusariosis developing in a post-irradiation site. Dermatol Online J 2011; 17 (5) 5
79 De Pinho DB, Fernandes LL, Carvalho Barreiros MdaG, Quintella LP, Sodré CT, Ramos-E-Silva M. Disseminated fusariosis in a bone marrow transplant patient. J Clin Aesthet Dermatol 2012; 5 (12) 40-42
80 Dony A, Perpoint T, Ducastelle S, Ferry T. Disseminated fusariosis with immune reconstitution syndrome and cracking mycotic aortic aneurysm in a 55-year-old patient with acute myeloid leukaemia. BMJ Case Rep 2013; 2013: 1-2
81 Dutta P, Premkumar A, Chakrabarti A , et al. Fusarium falciforme infection of foot in a patient with type 2 diabetes mellitus: a case report and review of the literature. Mycopathologia 2013; 176 (3-4) 225-232
82 Ersal T, Al-Hatmi AS, Cilo BD , et al. Fatal disseminated infection with Fusarium petroliphilum . Mycopathologia 2015; 179 (1-2) 119-124
83 Fanci R, Pini G, Bartolesi AM, Pecile P. Refractory disseminated fusariosis by Fusarium verticillioides in a patient with acute myeloid leukaemia relapsed after allogeneic hematopoietic stem cell transplantation: a case report and literature review. Rev Iberoam Micol 2013; 30 (1) 51-53
84 Gupta S, Almyroudis NG, Battiwalla M , et al. Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2007; 9 (2) 156-160
85 Ho DY, Lee JD, Rosso F, Montoya JG. Treating disseminated fusariosis: amphotericin B, voriconazole or both?. Mycoses 2007; 50 (3) 227-231
86 Inano S, Kimura M, Iida J, Arima N. Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review. J Infect Chemother 2013; 19 (6) 1173-1180
87 Jørgensen JS, Prause JU, Kiilgaard JF. Bilateral endogenous Fusarium solani endophthalmitis in a liver-transplanted patient: a case report. J Med Case Reports 2014; 8: 101
88 Jossi M, Ambrosioni J, Macedo-Vinas M, Garbino J. Invasive fusariosis with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature. Int J Infect Dis 2010; 14 (4) e354-e356
89 Kah TA, Yong KC, Rahman RA. Disseminated fusariosis and endogenous fungal endophthalmitis in acute lymphoblastic leukemia following platelet transfusion possibly due to transfusion-related immunomodulation. BMC Ophthalmol 2011; 11: 30
90 Kapp M, Schargus M, Deuchert T , et al. Endophthalmitis as primary clinical manifestation of fatal fusariosis in an allogeneic stem cell recipient. Transpl Infect Dis 2011; 13 (4) 374-379
91 Kawashima N, Yoshida N, Matsushita N, Ito M, Matsumoto K, Kato K. Intra-articular injection of voriconazole for Fusarium solani arthritis after bone marrow transplantation. J Infect 2012; 65 (4) 366-367
92 Kebabcı N, van Diepeningen AD, Ener B , et al. Fatal breakthrough infection with Fusarium andiyazi: new multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay. Mycoses 2014; 57 (4) 249-255
93 Kim MS, Lee HM, Sung HS , et al. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy. Int J Dermatol 2012; 51 (5) 621-623
94 Labois A, Gray C, Lepretre S. Successful treatment of disseminated fusariosis with voriconazole in an acute lymphoblastic leukaemia patient. Mycoses 2011; 54 (Suppl. 04) 8-11
95 Lewis R, Hogan H, Howell A, Safdar A. Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection. Leuk Lymphoma 2008; 49 (1) 163-165
96 Liu JY, Chen WT, Ko BS , et al. Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: a case report and literature review. Med Mycol 2011; 49 (8) 872-878
97 Mehta A, Bellam N. Disseminated fusariosis during acute myelogenous leukemia induction treatment. Blood 2014; 123 (22) 3379
98 Morel LN, Cid PM, De Celada RM , et al. Disseminated fusariosis in a pediatric population. Pediatr Dermatol 2013; 30 (6) e255-e256
99 Nunes MdoC, Barbosa FB, Gomes GH, Bráulio R, Nicoliello MF, Ferrari TC. Fatal right-sided endocarditis caused by Fusarium in an immunocompromised patient: a case report. Mycoses 2011; 54 (5) 460-462
100 Olivares R, Alfaro J, Díaz MC, Thompson L. [Disseminated fusariosis by Fusarium oxysporum in an adult patient with acute myeloid leukemia and severe febrile neutropenia]. Rev Chilena Infectol 2005; 22 (4) 356-360
101 Pereira GH, de Angelis DA, Brasil RA , et al. Disseminated amphotericin-resistant fusariosis in acute leukemia patients: report of two cases. Mycopathologia 2013; 175 (1-2) 107-114
102 Perini GF, Camargo LF, Lottenberg CL, Hamerschlak N. Disseminated fusariosis with endophthalmitis in a patient with hematologic malignancy. Einstein (Sao Paulo) 2013; 11 (4) 545-546
103 Rekha A, Kindo AJ, Ravi A. Fusarium solani in the post-transplant patient: an unusual fungus. Int J Low Extrem Wounds 2008; 7 (1) 38-40
104 Sandberg Y, Clahsen-van Groningen MC, Ammatuna E. Disseminated fusariosis. Int J Infect Dis 2015; 30: 154-155
105 Seyfarth F, Ziemer M, Sayer HG , et al. The use of ITS DNA sequence analysis and MALDI-TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum . Exp Dermatol 2008; 17 (11) 965-971
106 Stanzani M, Vianelli N, Bandini G , et al. Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. J Infect 2006; 53 (6) e243-e246
107 Tan R, Ng KP, Gan GG, Na SL. Fusarium sp. infection in a patient with acute lymphoblastic leukaemia. Med J Malaysia 2013; 68 (6) 479-480
108 Uludokumacı S, Balkan II, Mete B, Ozaras R, Saltoğlu N, Soysal T. Ecthyma gangrenosum-like lesions in a febrile neutropenic patient with simultaneous pseudomonas sepsis and disseminated fusariosis. Turk J Haematol 2013; 30 (3) 321-324
109 Vagace JM, Sanz-Rodriguez C, Casado MS , et al. Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. BMC Infect Dis 2007; 7: 40
110 Zegarra-Linares R, Wang ZJ, Lephart P, Poulik J, Rongkavilit C. A knee ulcer in a teenager with acute myeloid leukemia. Pediatr Infect Dis J 2012; 31 (10) 1100 , 1104–1105
111 de Souza M, Matsuzawa T, Lyra L , et al. Fusarium napiforme systemic infection: case report with molecular characterization and antifungal susceptibility tests. Springerplus 2014; 3: 492
112 Mikulska M, Furfaro E, Del Bono V , et al. Galactomannan testing might be useful for early diagnosis of fusariosis. Diagn Microbiol Infect Dis 2012; 72 (4) 367-369
113 Neuburger S, Massenkeil G, Seibold M , et al. Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation. Transpl Infect Dis 2008; 10 (4) 290-293
114 Petit A, Tabone MD, Moissenet D , et al. [Disseminated Fusarium infection in two neutropenic children]. Arch Pediatr 2005; 12 (7) 1116-1119
115 Silva GM, Silveira AR, Betânia CA, Macêdo DP, Neves RP. Disseminated fusariosis secondary to neuroblastoma with fatal outcome. Mycopathologia 2013; 176 (3-4) 233-236
116 Tezcan G, Ozhak-Baysan B, Alastruey-Izquierdo A , et al. Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation. J Clin Microbiol 2009; 47 (1) 278-281
117 Wu CH, Lu PL, Hsiao HH , et al. Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis. Ann Hematol 2014; 93 (6) 1079-1081
118 Zhang CZ, Fung MA, Eisen DB. Disseminated fusariosis presenting as panniculitis-like lesions on the legs of a neutropenic girl with acute lymphoblastic leukemia. Dermatol Online J 2009; 15 (10) 5
119 Wheeler MS, McGinnis MR, Schell WA, Walker DH. Fusarium infection in burned patients. Am J Clin Pathol 1981; 75 (3) 304-311
120 Sturm AW, Grave W, Kwee WS. Disseminated Fusarium oxysporum infection in patient with heatstroke. Lancet 1989; 1 (8644) 968
121 Madhavan M, Ratnakar C, Veliath AJ, Kanungo R, Smile SR, Bhat S. Primary disseminated fusarial infection. Postgrad Med J 1992; 68 (796) 143-144
122 Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, Kontoyiannis DP. Imaging of pulmonary fusariosis in patients with hematologic malignancies. AJR Am J Roentgenol 2008; 190 (6) 1605-1609
123 Nucci M, Varon AG, Garnica M , et al. Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil. Emerg Infect Dis 2013; 19 (10) 1567-1572
124 Varon AG, Nouer SA, Barreiros G , et al. Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis. J Infect 2014; 68 (1) 85-89
125 Nucci M, Nouér SA, Cappone D, Anaissie E. Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome. Haematologica 2013; 98 (11) 1657-1660
126 Nucci M, Marr KA, Vehreschild MJ , et al. Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect 2014; 20 (6) 580-585
127 Guinvarc'h A, Guilbert L, Marmorat-Khuong A , et al. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses 1998; 41 (1-2) 59-61
128 Vyzantiadis TA, Johnson EM, Kibbler CC. From the patient to the clinical mycology laboratory: how can we optimise microscopy and culture methods for mould identification?. J Clin Pathol 2012; 65 (6) 475-483
129 Nucci M, Carlesse F, Cappellano P , et al. Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing. PLoS ONE 2014; 9 (1) e87784
130 Grigis A, Farina C, Symoens F, Nolard N, Goglio A. Nosocomial pseudo-outbreak of Fusarium verticillioides associated with sterile plastic containers. Infect Control Hosp Epidemiol 2000; 21 (1) 50-52
131 O'Donnell K, Sutton DA, Rinaldi MG , et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 2010; 48 (10) 3708-3718
132 Triest D, Stubbe D, De Cremer K , et al. Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus. J Clin Microbiol 2015; 53 (2) 465-476
133 Okubo Y, Shinozaki M, Wakayama M , et al. Applied gene histopathology: identification of Fusarium species in FFPE tissue sections by in situ hybridization. Methods Mol Biol 2013; 968: 141-147
134 Mrazek C, Lass-Flörl C. Biopsy procedures for molecular tissue diagnosis of invasive fungal infections. Curr Infect Dis Rep 2011; 13 (6) 504-509
135 Montone KT, LiVolsi VA, Lanza DC , et al. In situ hybridization for specific fungal organisms in acute invasive fungal rhinosinusitis. Am J Clin Pathol 2011; 135 (2) 190-199
136 Montone KT. Differentiation of Fusarium from Aspergillus species by colorimetric in situ hybridization in formalin-fixed, paraffin-embedded tissue sections using dual fluorogenic-labeled LNA probes. Am J Clin Pathol 2009; 132 (6) 866-870
137 Sugawara Y, Nakase K, Nakamura A , et al. Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders. Eur J Haematol 2013; 90 (4) 331-339
138 Landlinger C, Preuner S, Willinger B , et al. Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology. J Clin Microbiol 2009; 47 (4) 1063-1073
139 Gu Z, Buelow DR, Petraitiene R, Petraitis V, Walsh TJ, Hayden RT. Quantitative multiplexed detection of common pulmonary fungal pathogens by labeled primer polymerase chain reaction. Arch Pathol Lab Med 2014; 138 (11) 1474-1480
140 Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med 2012; 125 (1, Suppl): S14-S24
141 Odabasi Z, Mattiuzzi G, Estey E , et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39 (2) 199-205
142 Ostrosky-Zeichner L, Alexander BD, Kett DH , et al. Multicenter clinical evaluation of the (1—>3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41 (5) 654-659
143 Nucci M, Garnica M, Reis H , et al. Performance of 1,3-beta-D-glucan (BDG) in the diagnosis and monitoring of invasive fusariosis. Paper presented at the 23rd European Congress of Clinical Microbiology and Infectious Diseases, April 27–30, 2013; Berlin, Abstract O-166
144 Min Z, Baddley JW, Rodriguez JM, Moser SA, Patel M. Cross-reactivity of Aspergillus galactomannan in an HIV-infected patient with histoplasmosis. Med Mycol Case Rep 2012; 1 (1) 119-122
145 Van Der Veer J, Lewis RJ, Emtiazjoo AM, Allen SD, Wheat LJ, Hage CA. Cross-reactivity in the Platelia™ Aspergillus enzyme immunoassay caused by blastomycosis. Med Mycol 2012; 50 (4) 396-398
146 Fekkar A, Brun S, D'Ussel M , et al. Serum cross-reactivity with Aspergillus galactomannan and cryptococcal antigen during fatal disseminated Trichosporon dermatis infection. Clin Infect Dis 2009; 49 (9) 1457-1458
147 Cummings JR, Jamison GR, Boudreaux JW, Howles MJ, Walsh TJ, Hayden RT. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn Microbiol Infect Dis 2007; 59 (1) 113-115
148 Tortorano AM, Esposto MC, Prigitano A , et al. Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol 2012; 50 (3) 1051-1053
149 Azor M, Gené J, Cano J, Manikandan P, Venkatapathy N, Guarro J. Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility. J Clin Microbiol 2009; 47 (5) 1463-1468
150 Azor M, Cano J, Gené J, Guarro J. High genetic diversity and poor in vitro response to antifungals of clinical strains of Fusarium oxysporum . J Antimicrob Chemother 2009; 63 (6) 1152-1155
151 Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008; 61 (4) 805-809
152 Tortorano AM, Prigitano A, Dho G , et al. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother 2008; 52 (7) 2683-2685
153 Nucci M, Anaissie E. How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach. Blood 2014; 124 (26) 3858-3869
154 Lerolle N, Raffoux E, Socie G , et al. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. Clin Microbiol Infect 2014; 20 (11) O952-O959